| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1424183 | Journal of Controlled Release | 2013 | 15 Pages |
Abstract
MWCNTs in the ‘nanotube–drug’ hybrids can play a role of carriers or additives (enhancers) in the more complex formulations. This work reviews qualitative and quantitative analyses of Drug Delivery Systems (DDSs) based on multi-wall carbon nanotubes (MWCNTs) and their chemically modified analogues (mainly oxidised MWCNTs). A special emphasis was placed on the chemical interactions between drug molecules and the nanotube carrier critical both in the stage of preparation/synthesis of the hybrids and liberation of the drug.
Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (199 K)Download as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Materials Science
Biomaterials
Authors
Sławomir Boncel, Piotr Zając, Krzysztof K.K. Koziol,